IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cascadian Therapeutics Inc

CUSIP: 14740B101 | 87 institutional holders

Quarters

Q4 2016Q3 2016Q2 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2016

Prelude Capital Management, LLC100
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Prelude Capital Management, LLC
100$00.0%Deep ValueVery HighNew York, NY2017-02-14